Ambu (AMBU B) 주식 개요
의료 기술 회사인 Ambu A/S는 전 세계 병원, 진료소 및 구조 서비스에 의료 기기를 개발, 생산 및 판매하는 기업입니다. 자세히 보기
강점
위험 분석
AMBU B가 우리의 위험 점검을 통과했습니다.
AMBU B Community Fair Values
Create NarrativeSee what 14 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Ambu A/S 경쟁사
가격 이력 및 성과
| 과거 주가 | |
|---|---|
| 현재 주가 | DKK 68.15 |
| 52주 최고가 | DKK 111.80 |
| 52주 최저가 | DKK 60.45 |
| 베타 | 1.26 |
| 1개월 변동 | 0.15% |
| 3개월 변동 | -16.33% |
| 1년 변동 | -32.52% |
| 3년 변동 | -37.93% |
| 5년 변동 | -70.74% |
| IPO 이후 변동 | 3,879.56% |
최근 뉴스 및 업데이트
내러티브 업데이트 • May 19
AMBU B: Lower P/E Expectations Will Support Future Upside Repricing
Analysts have trimmed their price target on Ambu from DKK 110.34 to DKK 88.80, reflecting a more cautious stance following a downgrade in recent research. The revised target still assumes steady revenue growth and a lower future P/E multiple.분석 기사 • May 09
Ambu A/S Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next
As you might know, Ambu A/S ( CPH:AMBU B ) last week released its latest quarterly, and things did not turn out so...
내러티브 업데이트 • May 04
AMBU B: Higher Growth And Margins Are Expected To Support Future Upside
Analysts have reduced their price target on Ambu by DKK 12. This reflects updated views on discount rates, expected revenue growth, profit margins and future P/E assumptions.내러티브 업데이트 • Apr 20
AMBU B: Reset P/E Assumptions Will Support Future Upside Repricing
Ambu's analyst price target has been reduced by DKK 12 to reflect updated views on its P/E assumptions, revenue growth profile and profitability, with analysts pointing to the recent DKK 12 target cut cited in Street research. Analyst Commentary JPMorgan's DKK 12 reduction in its Ambu price target reflects a reset of P/E expectations and a more cautious stance on the company's revenue growth and profitability profile.Recent updates
내러티브 업데이트 • May 19
AMBU B: Lower P/E Expectations Will Support Future Upside Repricing
Analysts have trimmed their price target on Ambu from DKK 110.34 to DKK 88.80, reflecting a more cautious stance following a downgrade in recent research. The revised target still assumes steady revenue growth and a lower future P/E multiple.분석 기사 • May 09
Ambu A/S Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next
As you might know, Ambu A/S ( CPH:AMBU B ) last week released its latest quarterly, and things did not turn out so...내러티브 업데이트 • May 04
AMBU B: Higher Growth And Margins Are Expected To Support Future Upside
Analysts have reduced their price target on Ambu by DKK 12. This reflects updated views on discount rates, expected revenue growth, profit margins and future P/E assumptions.내러티브 업데이트 • Apr 20
AMBU B: Reset P/E Assumptions Will Support Future Upside Repricing
Ambu's analyst price target has been reduced by DKK 12 to reflect updated views on its P/E assumptions, revenue growth profile and profitability, with analysts pointing to the recent DKK 12 target cut cited in Street research. Analyst Commentary JPMorgan's DKK 12 reduction in its Ambu price target reflects a reset of P/E expectations and a more cautious stance on the company's revenue growth and profitability profile.내러티브 업데이트 • Apr 06
AMBU B: Refined Discount Rate And P/E Expectations Will Support Future Upside
Analysts have lowered their price target on Ambu by DKK 12. This reflects small adjustments to fair value, discount rate, revenue growth, profit margin and future P/E assumptions following recent research updates.내러티브 업데이트 • Mar 22
AMBU B: Lower P/E Assumptions Will Support Upside If Execution Improves
Analysts have lowered their price target on Ambu by DKK 12 to reflect slightly adjusted assumptions on fair value, discount rate, revenue growth, profit margin, and future P/E following the recent JPMorgan target cut to DKK 12. Analyst Commentary Bullish Takeaways Bullish analysts see the revised fair value and discount rate assumptions as a reset that could leave room for upside if Ambu delivers on its operational targets.내러티브 업데이트 • Mar 08
AMBU B: Share Repurchase Mandate And Lowered Fair Value Will Support Upside
Analysts have trimmed their price target on Ambu by DKK 12 to reflect updated assumptions on fair value, discount rates and earnings expectations following recent research commentary. Analyst Commentary Bullish Takeaways Bullish analysts view the revised DKK 12 lower price target as still consistent with a supportive fair value range.내러티브 업데이트 • Feb 22
AMBU B: Share Buybacks And Margin Discipline Will Support Future Upside
The analyst price target for Ambu has been trimmed by DKK 1 to DKK 138, as analysts factor in slightly more cautious assumptions on growth, margins and discount rates following recent price target adjustments, such as the DKK 12 cut highlighted by JPMorgan. Analyst Commentary Bullish analysts remain focused on how Ambu can justify its current valuation through consistent execution on its growth plans, even as some price targets, including the DKK 12 adjustment flagged by JPMorgan, are recalibrated.
내러티브 업데이트 • Feb 08
AMBU B: Higher Risk Premium And Margin Pressure Will Reshape Share Outlook
The analyst price target for Ambu has been reduced from DKK 94.54 to DKK 78.00. This change reflects analysts’ updated assumptions on discount rate, revenue growth, profit margin and future P/E, as highlighted by recent Street research including a DKK 12 target cut.분석 기사 • Feb 08
Earnings Miss: Ambu A/S Missed EPS By 8.7% And Analysts Are Revising Their Forecasts
Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 3.3% to close at kr.87.90 following the...내러티브 업데이트 • Jan 25
AMBU B: Share Repurchases And Dividend Policy Will Support Future Upside
Analysts have slightly reduced their price target on Ambu, citing modest revisions to fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Together, these changes support a more cautious yet still constructive view on the shares.내러티브 업데이트 • Jan 11
AMBU B: Share Buybacks And Dividend Policy Will Support Future Upside
Analysts now set Ambu's price target at €139, down from €147, citing updated assumptions for discount rates, revenue growth, profit margins and future P/E that adjust their valuation framework. What's in the News Ambu A/S is set to be removed from the OMX Copenhagen 20 Index, which may affect how some index and benchmark focused investors view or hold the stock (Key Developments).분석 기사 • Jan 03
Ambu A/S' (CPH:AMBU B) Price In Tune With Earnings
With a price-to-earnings (or "P/E") ratio of 37.7x Ambu A/S ( CPH:AMBU B ) may be sending very bearish signals at the...내러티브 업데이트 • Dec 19
AMBU B: Dividend And Share Buybacks Will Drive Future Upside Potential
Analysts have trimmed their price target for Ambu slightly, lowering fair value by about 1 dollar per share as modestly slower expected revenue growth and profit margins are only partly offset by a slightly higher future P/E multiple and lower discount rate. What's in the News Ambu has launched a new share repurchase program starting December 10, 2025, allowing buybacks of up to 10% of its share capital under a mandate valid until December 13, 2027 (company announcement) The company announced an annual dividend of DKK 0.41 per share, payable on December 8, 2025, with an ex date of December 4 and record date of December 5, 2025 (company announcement) For fiscal 2025/26, Ambu issued guidance for 10% to 13% organic growth and an EBIT margin of 12% to 14%, or 14% to 16% excluding roughly 2 percentage points of tariff impacts (company guidance) Ambu reaffirmed its 2024/25 financial guidance, maintaining expectations for 12% to 14% organic revenue growth (company guidance) Valuation Changes Fair Value Estimate edged down slightly from DKK 115.59 to DKK 114.79 per share, reflecting a modestly lower fundamental valuation.분석 기사 • Dec 12
An Intrinsic Calculation For Ambu A/S (CPH:AMBU B) Suggests It's 34% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, Ambu fair value estimate is kr.130 Ambu's kr.85.60 share price...내러티브 업데이트 • Dec 05
AMBU B: Dividend Initiation And Margin Outlook Will Support Future Upside
Analysts have modestly raised their price target on Ambu by DKK 0.00 to reflect a slightly higher discount rate and updated profitability assumptions, while maintaining largely unchanged views on long term growth and valuation multiples. What's in the News Ambu A/S announced an annual dividend of DKK 0.41 per share, payable on December 8, 2025, with ex-date December 4 and record date December 5, 2025 (Key Developments).분석 기사 • Nov 27
We Think Shareholders Are Less Likely To Approve A Pay Rise For Ambu A/S' (CPH:AMBU B) CEO For Now
Key Insights Ambu's Annual General Meeting to take place on 3rd of December Salary of kr.8.01m is part of CEO Britt...내러티브 업데이트 • Nov 21
AMBU B: Improved Margins And Dividend Outlook Will Support Bullish Momentum
Analysts have slightly lowered their fair value price target for Ambu from DKK 121.41 to DKK 115.59, citing modest decreases in projected revenue growth and profit margin expectations. What's in the News Ambu A/S announced an annual dividend of DKK 0.4100 per share.내러티브 업데이트 • Nov 06
AMBU B: Higher Profit Margins Will Drive Hospital Efficiency Improvements
Analysts have revised their fair value estimate for Ambu down from DKK 130.70 to DKK 121.41. They cite a slightly higher discount rate, even though profit margin and revenue growth projections have improved.분석 기사 • Oct 07
Ambu (CPH:AMBU B) Has More To Do To Multiply In Value Going Forward
To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...분석 기사 • Aug 27
Ambu A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 3.4% to close at kr.98.20 following the...분석 기사 • Aug 11
Is Ambu A/S (CPH:AMBU B) Trading At A 35% Discount?
CPSE:AMBU B 1 Year Share Price vs Fair Value Explore Ambu's Fair Values from the Community and select yours Key...분석 기사 • Jul 12
Should You Think About Buying Ambu A/S (CPH:AMBU B) Now?
Ambu A/S ( CPH:AMBU B ), is not the largest company out there, but it saw significant share price movement during...분석 기사 • May 15
Ambu's (CPH:AMBU B) Earnings Offer More Than Meets The Eye
The stock was sluggish on the back of Ambu A/S' ( CPH:AMBU B ) recent earnings report. We have done some analysis, and...분석 기사 • Mar 14
Is Now The Time To Put Ambu (CPH:AMBU B) On Your Watchlist?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...분석 기사 • Feb 02
Earnings Miss: Ambu A/S Missed EPS By 6.2% And Analysts Are Revising Their Forecasts
Ambu A/S ( CPH:AMBU B ) last week reported its latest quarterly results, which makes it a good time for investors to...분석 기사 • Jan 27
Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...분석 기사 • Jan 12
Revenues Tell The Story For Ambu A/S (CPH:AMBU B) As Its Stock Soars 27%
Ambu A/S ( CPH:AMBU B ) shareholders would be excited to see that the share price has had a great month, posting a 27...분석 기사 • Dec 31
Is It Too Late To Consider Buying Ambu A/S (CPH:AMBU B)?
Ambu A/S ( CPH:AMBU B ), is not the largest company out there, but it received a lot of attention from a substantial...
새로운 내러티브 • Dec 16
Innovative aScope 5 Uretero And Sustainable Initiatives Will Accelerate Revenue Growth
Strategic focus on new high-value product launches and sustainability efforts could enhance revenue growth, product adoption, and brand perception while supporting long-term profitability.분석 기사 • Nov 28
Here's Why It's Unlikely That Ambu A/S' (CPH:AMBU B) CEO Will See A Pay Rise This Year
Key Insights Ambu will host its Annual General Meeting on 4th of December CEO Britt Jensen's total compensation...분석 기사 • Nov 13
Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality
Ambu A/S ( CPH:AMBU B ) just reported healthy earnings but the stock price didn't move much. Our analysis suggests that...분석 기사 • Nov 07
Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts
Shareholders might have noticed that Ambu A/S ( CPH:AMBU B ) filed its full-year result this time last week. The early...분석 기사 • Sep 02
Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next
It's been a sad week for Ambu A/S ( CPH:AMBU B ), who've watched their investment drop 10% to kr.128 in the week since...분석 기사 • Aug 06
Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...분석 기사 • Apr 06
Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity
With a median price-to-sales (or "P/S") ratio of close to 6.1x in the Medical Equipment industry in Denmark, you could...분석 기사 • Mar 14
Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...분석 기사 • Feb 01
Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates
Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 2.9% to close at kr.115 following the release...분석 기사 • Jan 02
A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price
It's not a stretch to say that Ambu A/S' ( CPH:AMBU B ) price-to-sales (or "P/S") ratio of 5.9x right now seems quite...분석 기사 • Oct 31
Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?
Key Insights Ambu's estimated fair value is kr.114 based on 2 Stage Free Cash Flow to Equity Ambu's kr.66.00 share...주주 수익률
| AMBU B | DK Medical Equipment | DK 시장 | |
|---|---|---|---|
| 7D | 9.1% | 3.1% | 0.09% |
| 1Y | -32.5% | -27.0% | -14.4% |
수익률 대 산업: AMBU B은 지난 1년 동안 -27%의 수익을 기록한 Danish Medical Equipment 산업보다 저조한 성과를 냈습니다.
수익률 대 시장: AMBU B은 지난 1년 동안 -14.4%를 기록한 Danish 시장보다 저조한 성과를 냈습니다.
주가 변동성
| AMBU B volatility | |
|---|---|
| AMBU B Average Weekly Movement | 4.8% |
| Medical Equipment Industry Average Movement | 4.8% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in DK Market | 9.1% |
| 10% least volatile stocks in DK Market | 2.9% |
안정적인 주가: AMBU B는 지난 3개월 동안 Danish 시장에 비해 주가 변동성이 크지 않았습니다.
시간에 따른 변동성: AMBU B의 주간 변동성(5%)은 지난 1년 동안 안정적이었습니다.
회사 소개
| 설립 | 직원 수 | CEO | 웹사이트 |
|---|---|---|---|
| 1937 | 5,200 | Britt Jensen | www.ambu.com |
의료 기술 회사인 Ambu A/S는 전 세계 병원, 진료소 및 구조 서비스에 의료 기기를 개발, 생산 및 판매하는 회사입니다. 이 회사는 마취, 환자 모니터링 및 진단 제품을 제공합니다. 또한 기관지경, 비인두경, 십이지장경, 위내시경, 방광경, 디스플레이 장치와 같은 내시경 제품과 뇌파 및 근전도 전극, 근전도 유도 주사기, 수술 중 모니터링 제품을 포함한 신경과 제품도 제공합니다.
Ambu A/S 기초 지표 요약
| AMBU B 기초 통계 | |
|---|---|
| 시가총액 | DKK 18.04b |
| 순이익 (TTM) | DKK 477.00m |
| 매출 (TTM) | DKK 6.10b |
37.8x
주가수익비율(P/E)3.0x
주가매출비율(P/S)AMBU B는 고평가되어 있습니까?
공정 가치 및 평가 분석 보기순이익 및 매출
| AMBU B 손익계산서 (TTM) | |
|---|---|
| 매출 | DKK 6.10b |
| 매출원가 | DKK 2.44b |
| 총이익 | DKK 3.66b |
| 기타 비용 | DKK 3.18b |
| 순이익 | DKK 477.00m |
최근 보고된 실적
Mar 31, 2026
다음 실적 발표일
Aug 26, 2026
| 주당순이익(EPS) | 1.80 |
| 총이익률 | 59.98% |
| 순이익률 | 7.81% |
| 부채/자본 비율 | 0.3% |
AMBU B의 장기 실적은 어땠습니까?
과거 실적 및 비교 보기배당
0.6%
현재 배당 수익률23%
배당 성향기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/05/22 12:44 |
| 종가 | 2026/05/22 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2025/09/30 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Ambu A/S는 14명의 분석가가 다루고 있습니다. 이 중 8명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| null null | ABG Sundal Collier |
| Michael Healy | Berenberg |
| Susannah Ludwig | Bernstein |